Pseudomonas Superbug Develops Fast Resistance to ‘Last Resort’ Antibiotic
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a "last resort" antibiotic.
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a "last resort" antibiotic.
A new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.